Physician

Mohammad Entezari Taher, MD

According to 2025 Medicare claims, Mohammad Taher, MD (NPI: 1992762918) practices neurology in the Provo-Orem-Lehi, UT market, with the plurality of this provider's patient population coming from Utah, UT. This provider's primary affiliated billing organization is NEUROLOGICAL ASSOCIATES LLC (NPI: 1912963372; TIN: 870507858) and primary practice location at 84003-2829. Taher is affiliated with the Aledade 201 National MSSP (ACO ID: A5522) and Imperium Clinical Partners II, LLC (ACO ID: A5523), participating under the MSSP model.

Taher's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 372 traditional Medicare patients, billed 25,065 HCPCS/CPT codes, and received $248,646 in Medicare payments. The top billing code was 95911 (Nerve conduction, 9-10 studies). Part D data shows 2,541 prescription claims across 369 beneficiaries totaling $811,549 in drug costs, led by Aubagio (Teriflunomide). DME data shows 80 claims. Open Payments data shows 142 records totaling $8,784. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $288,868 to $811,549. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $7,467 and ending at $4,920.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	799	18,206	$302,028
2016	792	18,139	$277,011
2017	791	25,114	$311,295
2018	774	27,013	$312,482
2019	762	29,821	$329,525
2020	519	31,546	$301,231
2021	504	33,969	$317,312
2022	439	31,946	$291,142
2023	434	28,778	$287,013
2024	372	25,065	$248,646

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	157	1,099	$288,868
2016	185	1,373	$317,538
2017	190	1,573	$516,594
2018	183	1,517	$459,196
2019	200	1,752	$290,804
2020	222	1,825	$748,867
2021	264	2,026	$888,301
2022	284	2,259	$706,177
2023	282	2,193	$829,146
2024	369	2,541	$811,549

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	98	$3,525
2016	N/R	82	$2,659
2017	N/R	89	$2,803
2018	26	124	$3,856
2019	25	115	$3,277
2020	37	182	$4,774
2021	N/R	40	$1,068
2022	N/R	41	$629
2023	N/R	11	$175
2024	N/R	80	$2,848

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95911	Nerve conduction, 9-10 studies	122	140	$153
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	180	300	$89
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	126	279	$72
96116	Exam of neurobehavioral status, first hour	74	87	$67
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	177	284	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Aubagio	Teriflunomide	17	510	$156,330
Tecfidera	Dimethyl Fumarate	12	360	$113,529
Vumerity	Diroximel Fumarate	11	330	$96,753
Botox	Onabotulinumtoxina	71	5,976	$95,062
Teriflunomide	Teriflunomide	13	508	$44,164

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	20	$1,537
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	34	$981
E0562	Humidifier, heated, used with positive airway pressure device	Y	N/R	26	$330

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	142	$8,784	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mohammad Entezari Taher, MD?

Tedicare shows public-source Medicare data for Mohammad Entezari Taher, MD (NPI 1992762918), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohammad Entezari Taher, MD have ACO affiliation data?

Mohammad Entezari Taher, MD is shown with ACO affiliation data for Aledade 201 National MSSP (MSSP, ACO ID A5522) and Imperium Clinical Partners II, LLC (MSSP, ACO ID A5523).

What billing organization is linked to Mohammad Entezari Taher, MD?

Mohammad Entezari Taher, MD is linked to NEUROLOGICAL ASSOCIATES LLC (billing NPI 1912963372) in the available physician profile data.

Does Mohammad Entezari Taher, MD have Open Payments data?

Mohammad Entezari Taher, MD has 142 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.